Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace.

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Ozempic, Wegovy, Zepbound, and Mounjaro are but a few of the injectable drugs that are currently revolutionizing the size of ...

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...

Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...

A phenomenon called 'Ozempic Babies' are raising concerns about weight loss drugs after multiple reports of surprise ...

The company shipped some 750 vials of testosterone to customers who had instead ordered tirzepatide, the active ingredient in ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...